I made four predictions about the stock market in 2024. The Fed indeed cut rates in Q4, but stocks didn't jump as much as I ...

Everfront Biotech Holding has filed for an initial public offering with the Securities and Exchange Commission. The biopharmaceutical company, which focuses on new drug discovery and development, didn ...

( MENAFN - Investor Ideas) Investorideas , a go-to platform for big investing ideas, including cleantech Stocks reports on trading and news for N2OFF, Inc. (NASDAQ: NITO ) (FSE:80W), a clean tech ...

Viking Therapeutics (VKTX) is identified by Oppenheimer among five potential biotech M&A candidates ahead of J.P. Morgan Healthcare Conference. Read more here.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Happy New Year, biotech ...

Will 2025 be better? After another tough year, the answer to that question will shape the prospects of innumerable drug ...

The co-developer of a US-approved drug, Professor Andrew Wilks has formed Synthesis Bioventures to sniff out more winners.

Macroeconomic factors have weighed on US stocks in the final days of the year, with the broader market declining by over 1% ...

We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a ...

We recently published a list of the 12 Best Biotech Penny Stocks To Invest In Now. In this article, we are going to take a ...

From public campaigns featuring Cyndi Lauper to ads with dinosaurs, MM+M compiles the best public marketing campaigns from ...